Woodline Partners’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-306,946
Closed -$253K 993
2025
Q1
$253K Sell
306,946
-2,651
-0.9% -$2.19K ﹤0.01% 868
2024
Q4
$294K Hold
309,597
﹤0.01% 889
2024
Q3
$310K Buy
+309,597
New +$310K ﹤0.01% 554
2023
Q4
Sell
-173,877
Closed -$226K 569
2023
Q3
$226K Hold
173,877
﹤0.01% 545
2023
Q2
$299K Hold
173,877
﹤0.01% 572
2023
Q1
$254K Buy
173,877
+94,742
+120% +$138K ﹤0.01% 576
2022
Q4
$128K Sell
79,135
-8,799
-10% -$14.3K ﹤0.01% 703
2022
Q3
$295K Sell
87,934
-251,439
-74% -$844K ﹤0.01% 619
2022
Q2
$1.24M Buy
339,373
+148,342
+78% +$540K 0.02% 493
2022
Q1
$1.38M Sell
191,031
-118,566
-38% -$857K 0.02% 444
2021
Q4
$4.21M Sell
309,597
-191,031
-38% -$2.6M 0.06% 307
2021
Q3
$10.5M Hold
500,628
0.17% 155
2021
Q2
$12M Buy
500,628
+312,543
+166% +$7.49M 0.22% 115
2021
Q1
$5.51M Sell
188,085
-33,402
-15% -$978K 0.12% 181
2020
Q4
$6.62M Buy
+221,487
New +$6.62M 0.18% 143